Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
30.19 CNY
5.01%
Market Closed
Updated:
May 28, 2024
Beijing Hotgen Biotech Co Ltd
Net Change in Cash
|
Beijing Hotgen Biotech Co Ltd
Net Change in Cash Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Net Change in Cash
-¥250.8m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Change in Cash
¥1.6B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Change in Cash
¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Change in Cash
¥3.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Change in Cash
-¥133m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Net Change in Cash
¥3.9B
|
CAGR 3-Years
477%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Net Change in Cash?
Net Change in Cash
-250.8m
CNY
-250.8m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Net Change in Cash amounts to -250.8m CNY.
What is Beijing Hotgen Biotech Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-84%
-84%
Over the last year, the Net Change in Cash growth was 60%. The average annual Net Change in Cash growth rates for Beijing Hotgen Biotech Co Ltd have been -84% over the past three years .
You don't have any saved screeners yet
